pensyarah perubatan
jabatan perubatan
drlela2020@yahoo.com
No. Telefon Rasmi : 6087/7305
No. rasmi:
UKM : 03 8921 5555
PENSYARAH PERUBATAN
sukor n, puar th, sunthornyothin s, kamaruddin na.. (2023). editorial: expanding spectrum of primary aldosteronism: exploring new grounds. - frontiers in endocrinology. 1-3.
m naruse, m murakami, t katabami...norlela sukor, elena a.b. aisha azizan.... (2023). international multicenter survey on screening and confirmatory testing in primary aldosteronism. - european journal of endocrinology. 1-10.
ruslinda mustafar, theepa nesam, lydia kamaruzaman, rozita mohd, norlela sukor, nazarudin safian, arbaiyah ba'in. (2023). serum vitamin d levels among immunoglobulin a nephropathy patients and the associated parameters. - medical journal of malaysia. 86-91.
norlela sukor, elena aisha azizan. (2023). editorial: adrenal related hypertension: from bench to bedside. - frontiers in endocrinology. 1-3.
fatin athirah pauzi, elena aisha azizan, muaatamarulain mustangin, geok chin tan, norlela sukor, ales ryska, jiri ceral, miroslav solar, azraai bahari nasruddin. (2023). distribution of cacna1d somatic mutations among cyp11b2 immunohistochemistry-guided samples of aldosterone-producing adenoma (apa). - journal of hypertension. e280-e281.
sukor n, puar th, sunthornyothin s, kamaruddin na.. (2023). editorial: expanding spectrum of primary aldosteronism: exploring new grounds. - frontiers in endocrinology. 1-3.
fatin athirah pauzi, elena aisha azizan, muaatamarulain mustangin, geok chin tan, norlela sukor, ales ryska, jiri ceral, miroslav solar, azraai bahari nasruddin. (2023). distribution of cacna1d somatic mutations among cyp11b2 immunohistochemistry-guided samples of aldosterone-producing adenoma (apa). - journal of hypertension. e280-e281.
siti khadijah syed mohammed nazri, rozman zakaria, nor azian abdul murad, rohaizak muhammad, geok chin tan, norlela sukor, elena aisha azizan. (2023). identification of aldosterone-driver somatic mutations in cell-free dna from adrenal vein samples of primary aldosteronism patients. - journal of hypertension. e487.
kha chin long, norlela sukor, geok chin tan, nor azian abdul murad, morris jonathan brown, elena aisha azizan. (2023). elucidating effect of inhibiting aldosterone synthesis on human adrenocortical cells. - journal of hypertension. e362.
norlela sukor, elena aisha azizan. (2023). editorial: adrenal related hypertension: from bench to bedside. - frontiers in endocrinology. 1-3.
noor ashikin ismail, nor azmi kamaruddin, shamsul azhar shah, norlela sukor. (2020). the effect of vitamin d treatment on clinical and biochemical outcomes of primary aldosteronism. - clinical endocrinology. 509-517.
huai heng loh, norlela sukor. (2020). associations between primary aldosteronism and diabetes, poor bone health, and sleep apnea what do we know so far. - journal of human hypertension. 5-15.
a raudhah, na wahab, r mohd, n kamaruddin, n sukor, n mustafa, a a gafor, w kong, ra cader, r mustafa. (2018). comparison of glycaemic variability with liraglutide vs. linagliptin in type 2 diabetic end stage renal disease on haemodialysis: a pilot study. - journal of diabetes investigation. .
shu teng chai, amalina haydar ali tajuddin, norasyikin a. wahab, norlaila mustafa, norlela sukor, and nor azmi kamaruddin. (2018). fluconazole as a safe and effective alternative to ketoconazole in controlling hypercortisolism of recurrent cushing`s disease: a case report. - international journal of endocrinology and metabolism. 1-5.
wh kang, j rohana, aw norasyikin, m norlaila, s sukor, kn azmi. (2018). weight loss and a1c reduction: our experience with dulaglutide. - journal of diabetes investigation. .
sukor n, puar th, sunthornyothin s, kamaruddin na.. (2023). editorial: expanding spectrum of primary aldosteronism: exploring new grounds. - frontiers in endocrinology. 1-3.
nurfatin syazreen mohd rizam, muaatamarulain mustangin, geok chin tan, norlela sukor, fatin saparuddin, fatin athirah pauzi, siti khadijah syed muhammad nazri, azraai bahari nasruddin, elena aisha azizan. (2023). prevalence of kcnj5 mutant aldosterone-producing adenomas among malaysian patients with primary aldosteronism. - journal of hypertension. e280.
ruslinda mustafar, theepa nesam, lydia kamaruzaman, rozita mohd, norlela sukor, nazarudin safian, arbaiyah ba'in. (2023). serum vitamin d levels among immunoglobulin a nephropathy patients and the associated parameters. - medical journal of malaysia. 86-91.
fatin athirah pauzi, elena aisha azizan, muaatamarulain mustangin, geok chin tan, norlela sukor, ales ryska, jiri ceral, miroslav solar, azraai bahari nasruddin. (2023). distribution of cacna1d somatic mutations among cyp11b2 immunohistochemistry-guided samples of aldosterone-producing adenoma (apa). - journal of hypertension. e280-e281.
m naruse, m murakami, t katabami...norlela sukor, elena a.b. aisha azizan.... (2023). international multicenter survey on screening and confirmatory testing in primary aldosteronism. - european journal of endocrinology. 1-10.
mohd yazid bin bajuri;abdul halim bin abdul gafor;norlela binti sukor;raja zahratul azma raja sabudin. (2022). efficacy of wf10 in treatment of diabetic neuropathic wound: a prospective controlled study. - . .
shiau chin chong , norlela sukor, sarah anne robert, kim fong ng, nor azmi kamaruddin. (2021). enhancement of total glucagon-like peptide-1 secretion in type 2 diabetes mellitus patients in malaysia. - 19th international congress of endocrinology. 1.
elena ab azizan, norlela b sukor. (2021). berpotensi pulih sepenuhnya. - metro. 38.
nor azmi kamaruddin, norlela sukor et al. (2021). clinical practice guidelines - management of type 2 diabetes mellitus. - . 1-284.
elena azizan, norlela sukor, morris brown. (2020). ace2: rakan atau musuh covid-19?. - the malaysian medical gazette. 1-12.
Geran / Grant | Kolaborator / Collaborator | Status |
---|---|---|
A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTRE PHASE 2B STUDY TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF AZD2693 IN PARTICIPANTS WITH NON-CIRRHOTIC NON-ALCOHOLIC STEATOHEPATITIS (NASH) WITH FIBROSIS WHO ARE CARRIERS OF THE PNPLA3.. | astrazeneca sdn bhd | 11.2% (2023-05-29 sehingga 2026-04-28) |
A PHASE IIB/III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF COTADUTIDE IN PARTICIPANTS WITH NON-CIRRHOTIC NON-ALCOHOLIC STEATOHEPATITIS WITH FIBROSIS | astrazeneca sdn. bhd. | 34% (2022-07-28 sehingga 2025-12-27) |